How does weight loss drug Mounjaro work and why is it in such high demand?
Briefly

from www.theguardian.com1 month ago
Mounjaro, produced by Eli Lilly, is a once-a-week injection that contains tirzepatide, helping improve blood sugar for type 2 diabetes and facilitating significant weight loss.
www.theguardian.comhttps://www.theguardian.com/society/2024/dec/07/how-does-weight-loss-drug-mounjaro-work-and-why-is-it-in-such-high-demand
While both Mounjaro and Wegovy work in similar ways by mimicking the GLP-1 hormone to reduce appetite, tirzepatide's additional action on GIP enhances its effectiveness, aiding greater weight loss.
www.theguardian.comhttps://www.theguardian.com/society/2024/dec/07/how-does-weight-loss-drug-mounjaro-work-and-why-is-it-in-such-high-demand
Clinical trials showed that tirzepatide led to an average weight loss of 17.8% compared to 12.4% for semaglutide, indicating a notable advantage for patients seeking weight management.
www.theguardian.comhttps://www.theguardian.com/society/2024/dec/07/how-does-weight-loss-drug-mounjaro-work-and-why-is-it-in-such-high-demand
With Mounjaro being prioritized for NHS use among patients with the highest needs, the rollout is structured over the next 12 years, addressing weight-related health issues.
www.theguardian.comhttps://www.theguardian.com/society/2024/dec/07/how-does-weight-loss-drug-mounjaro-work-and-why-is-it-in-such-high-demand
Read at www.theguardian.com
#weight-loss #nhs #tirzepatide #mounjaro #type-2-diabetes
[
|
]